Ricard Quingles

Ricard Quingles is a seasoned executive with extensive experience in business development, analytics, and corporate strategy across the healthcare industry. Currently serving as Chief Business Officer at Julius Clinical since March 2024, Ricard previously held the position of VP Business Expansion Europe at Innovaderm Research Inc. from December 2019 to March 2024, focusing on the development of innovative dermatology treatments. Prior roles include Strategy & Finance Advisor at humanITcare, Executive VP Business Analytics & Planning & Corporate Strategy, and Regional Managing Director South Europe at TFS Trial Form Support, as well as Finance Director positions at CDC Clinical Data Care and Amgen. Ricard began a professional career at Deloitte as an auditor. Ricard holds an MBA from Esade and a Licenciado in Ciencias Económicas y Empresariales from Universitat Pompeu Fabra.